Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02856269 · ClinicalTrials.gov registry record · NA
Zinc Supplementation and Cardiovascular Risk in HIV
A NA study of HIV and Inflammation, sponsored by Grace McComsey.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT02856269 is a NA study of HIV and Inflammation that has completed, run by Grace McComsey. The registered enrollment target is 52 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02856269, a NA study of HIV and Inflammation, has completed, sponsored by Grace McComsey.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine whether zinc supplementation significantly affects immune activation in HIV-infected subjects.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Zinc gluconate
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02856269
The ClinicalTrials.gov registry entry for NCT02856269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (88% lower). The listed sponsor is Grace McComsey, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Zinc gluconate is the first listed.
NCT02856269 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02856269 about?
NCT02856269 is a clinical study titled "Zinc Supplementation and Cardiovascular Risk in HIV". The purpose of this pilot study is to determine whether zinc supplementation significantly affects immune activation in HIV-infected subjects.
What is the current status of trial NCT02856269?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2016-09. Estimated completion is 2018-04-16.
What conditions does trial NCT02856269 study?
This clinical trial studies the following conditions: HIV, Inflammation.
What interventions are being tested in trial NCT02856269?
The interventions under investigation include: Zinc gluconate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02856269?
This trial is sponsored by Grace McComsey, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02856269 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.